NASDAQ · Financial Statements

Krystal Biotech, Inc. (KRYS) Financial Statements

$316.58 NASDAQ: KRYS Market Cap $9.37B

Krystal Biotech, Inc. most recently reported annual revenue of $389.0M, net profit of $205.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$51.0M$291.0M$389.0M
Operating Profit$-68.0M$-145.0M$-110.0M$66.0M$161.0M
Net Profit$-70.0M$-140.0M$11.0M$89.0M$205.0M
EPS$-3.13$-5.49$0.39$3.00$6.84
Op Margin——-216.4%22.6%41.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$626.0M$558.0M$818.0M$1.1B$1.3B
Total Liabilities$33.0M$36.0M$40.0M$109.0M$114.0M
Cash$341.0M$162.0M$358.0M$345.0M$496.0M
Borrowings$8.0M$9.0M$8.0M$7.0M$9.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-48.0M$-101.0M$-89.0M$123.0M$201.0M
Investing Cash Flow$-295.0M$-167.0M$71.0M$-168.0M$-70.0M
Financing Cash Flow$-8.0M$-1.0M$-1.0M$-5.0M$-14.0M
Net Cash Flow$73.0M$-179.0M$196.0M$-13.0M$151.0M
Free Cash Flow$-116.0M$-154.0M$-101.0M$119.0M$189.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.63
EV / EBITDA41.58
FCF Yield2.71%
Quick Ratio7.96
Interest Coverage—
Return 1Y75.68%
Return 3Y180.91%
Return 5Y528.72%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
KRYS Overview KRYS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.